MindRank
Business Services · China · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Shanghai, Shanghai, ChinaWebsite
www.mindrank.aiRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About MindRank
MindRank is an AI-powered drug discovery company that focus on "hard-to-drug targets" through their three proprietary technology platforms – end-to-end drug design platform Molecule Pro, molecular dynamics platform Molecule Dance and biomedical knowledge graph PharmKG.Explore more
MindRank Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is MindRank your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on MindRank recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if MindRank had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when MindRank launches new products
Congratulate Masked Content for being promoted to Masked Content at MindRank
Check if MindRank has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once MindRank has new funding data
Check out if MindRank is spiking on competitors!
MindRank, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Reach out to Masked Content who joined MindRank as Masked Content
Find 2 more new buyers
Company Profile Activity
Activity Insights
MindRank is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
MindRank is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about MindRank.
MindRank Tech Stack
A closer look at the technologies used by MindRank
MindRank News & Media
MindRank Initiates Phase III "MOBILE" Trial for MDR-001: an Oral GLP-1RA Small Molecule Engineered with AI
MindRank Initiates Phase III "MOBILE" Trial for MDR-001: an Oral GLP-1RA Small Molecule Engineered with AIMindRank in Phase 3 trial with China's first AI-assisted new drug, cutting R&D costs by 60%
The company was aiming for approval in the second half of 2028, paving the way for a market launch in 2029.MindRank Announces Positive 12-week Once-Daily (QD) Results for AI-Designed Oral GLP-1 Agonist MDR-001 in Adults with Obesity
Using an optimized once-daily (QD) regimen, MDR-001 achieved a body weight reduction of 8.9% over 12 weeks.MindRank Presented Clinical Update on Oral GLP-1RA MDR-001 at LSX World Congress, Highlighting AI-Powered Innovation
Mindrank delivered a keynote presentation entitled “AI-Designed Oral GLP-1RA: First-in-Class Phase IIb Clinical Readouts and Translational Insights”.
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding MindRank
Sign Up For FreeTo access detailed company insights
MindRank is an AI-powered drug discovery company that focus on "hard-to-drug targets" through their three proprietary technology platforms – end-to-end drug design platform Molecule Pro, molecular dynamics platform Molecule Dance and biomedical knowledge graph PharmKG.... Read More
